U.S. Leisure Stock News

Rockwell Automation (NYSE:ROK) has partnered with Laboratorios Farmacéuticos Rovi to deploy a fully digitalized batch execution system. The project replaces paper-based records and connects Rockwell’s FactoryTalk PharmaSuite MES with Rovi’s core business platforms. The system was completed in under a year and is planned to be rolled out across additional Rovi operations. For you as an investor, this is a concrete example of how Rockwell Automation is taking its software and digital services...

Northern Trust (NasdaqGS:NTRS) has partnered with Intercontinental Exchange's ICE ETF Hub to launch an automated ETF servicing platform for U.S. institutional investors. The new platform is aimed at providing end to end, fully automated ETF solutions across the U.S. institutional ETF servicing space. This agreement marks Northern Trust's entry into a new market segment within ETF servicing and broadens its service lineup for large investors. Northern Trust, trading at $136.92, is moving...

If you are wondering whether Becton Dickinson's current share price reflects its true worth, you are not alone. This article will walk you through what the numbers are saying about value. Becton Dickinson's share price closed at US$159.36, with returns of a 4.6% decline over 7 days, an 11.8% decline over 30 days, an 18.3% decline year to date, an 8.2% decline over 1 year, a 9.0% decline over 3 years and a 5.4% decline over 5 years. This raises questions about how the market is currently...

Gulfport Energy Corporation recently confirmed that President, Chief Executive Officer and Director John Reinhart resigned effective March 9, 2026, with an interim Office of the Chairman now overseeing the business while an external search for a new CEO is underway. The temporary leadership structure, headed by former CEO and current Chairman Timothy J. Cutt alongside key executives, is designed to preserve operational continuity and maintain the company’s stated development plans and...

Mondelez International has completed installation of a new production line at its Toblerone plant in Bern, advancing a previously announced CHF 65 million investment to create a global Center of Excellence and expand capacity for the premium chocolate brand, which already produces about 90% of its worldwide volume in Switzerland. This build-out of Toblerone’s Swiss hub strengthens Mondelez’s push into higher-end chocolate, combining increased production with an innovation platform aimed at...

What TFS Financial’s Recent Returns May Be Telling Investors TFS Financial (TFSL) has drawn attention after a mixed run in its share price, with a 0.4% move over the past day, weaker performance over the past month, but a stronger 1 year total return. For investors, the combination of recent short term weakness, a modest year to date decline, and a higher 3 year total return raises the question of whether the current share price still reflects the bank’s underlying retail-focused...

If you are wondering whether JBT Marel is priced fairly or offering value right now, this article walks through what the current share price might imply. The stock closed at US$129.64, with a 12.9% decline over the last week and a 21.6% decline over the last 30 days. The 1 year return sits at 5.3% and the 3 year return at 30.4%, against a 5 year return of a 3.3% decline. These mixed returns hint that the market has been reassessing the company, with recent moves likely reflecting changing...

Event context and recent performance Benchmark Electronics (BHE) has been drawing attention after a mixed run in recent trading, with a 1 day decline, a small gain over the past week, and a weaker month followed by a stronger past 3 months. For investors tracking consistency, the stock also shows positive year to date and 1 year total returns, alongside multi year total returns that reflect how the business has behaved over longer periods. See our latest analysis for Benchmark Electronics. At...

UCB reported that its arthritis drug Bimzelx outperformed AbbVie’s Skyrizi in a head to head clinical trial in psoriatic arthritis. The trial result introduces a new competitive challenge for one of NYSE:ABBV’s key immunology products in an important inflammatory disease indication. Early commentary points to limited immediate sales impact, and investors are watching how this could influence future positioning of Skyrizi within psoriatic arthritis. For context, AbbVie, ticker NYSE:ABBV, has...

In recent days, DNOW Inc. has faced pressure after disappointing fourth-quarter 2025 results, a significant loss, and the launch of a Rosen Law Firm investigation into potentially misleading business information, alongside a reduction in holdings by major shareholder Barrow Hanley Mewhinney & Strauss LLC. At the same time, DNOW is pursuing growth through its MRC Global deal and integration efforts, even as concerns mount over substandard operating margins, declining earnings per share and...

If you are wondering whether BETA Technologies at around US$16.65 is a bargain or a value trap, you are not alone. This article is here to unpack what the current price might be implying. The stock has had a rough patch recently, with a 13.6% decline over the last 7 days, a 14.1% decline over the last 30 days, and a 39.1% decline year to date, which can change how the market views both its potential and its risk. Recent news coverage has focused on BETA Technologies as part of broader...

Earlier in March 2026, Evergy, Inc. completed a US$349.96 million fixed‑income issuance of 4.250% senior unsecured notes due March 15, 2029, priced at 99.988% of principal and featuring a fixed coupon and callable structure. This bond deal, together with Evergy’s broader fixed‑rate notes program, adds financial flexibility that may influence how it funds planned grid and generation investments. With Evergy’s new US$350 million bond issuance in place, we’ll examine how this added funding...

Earlier this week, Truist Securities reaffirmed its positive view on Sila Realty Trust after the company posted fourth-quarter 2025 results with revenue modestly ahead of forecasts but earnings per share slightly behind expectations. The research update emphasized that Sila’s fully leased triple-net healthcare portfolio and cash flow coverage of its dividend remain central to the REIT’s appeal despite higher interest costs and isolated vacancies. With Truist spotlighting the resilience of...

If you are wondering whether Watsco’s current share price lines up with its underlying worth, you are not alone. This article will walk through what the numbers actually say about value. Watsco’s share price closed at US$368.39 recently, with returns of 6.1% year to date, a 25.5% decline over the past year, and gains of 34.7% over 3 years and 67.0% over 5 years. This gives a mixed picture for anyone trying to assess opportunity and risk. Recent price moves, including a 6.3% decline over the...

NVIDIA and Nebius Group N.V. recently announced a partnership under which NVIDIA will invest US$2.00 billion via pre-funded warrants, deepening collaboration across AI factory design, infrastructure deployment, and software to support Nebius’s plan to deploy over 5 gigawatts of AI capacity by 2030. The deal gives Nebius early access to NVIDIA’s next-generation Rubin platform, Vera CPUs, and BlueField storage systems, effectively tying the company’s hyperscale AI cloud roadmap directly into...

If you are wondering whether Check Point Software Technologies is attractively priced or not, this article walks through the key numbers so you can judge the stock's value with confidence. The share price last closed at US$153.65, with returns of 7% decline over 7 days, 6.6% decline over 30 days, 15.1% decline year to date, 31.7% decline over 1 year, 19.0% over 3 years and 31.7% over 5 years. This raises fair questions about how the market currently views its growth prospects and...

Why 1st Source Stock Is Drawing Investor Attention 1st Source (SRCE) is back on some investors’ radar after a recent stretch of mixed returns, including a small 1 day pullback and gains over the past 3 months and year. See our latest analysis for 1st Source. Recent trading has been relatively steady, with a 7 day share price return of 0.5% and a 90 day share price return of 3.0%, while the 1 year total shareholder return of 13.8% suggests momentum has been building over a longer horizon. If...

Universal Health Services (NYSE:UHS) has agreed to acquire virtual behavioral health provider Talkspace in a deal valued at about US$835 million. The transaction is structured as a definitive agreement and is expected to close later in 2026, subject to customary approvals. Talkspace brings a nationwide digital platform focused on behavioral health, which UHS plans to integrate into its existing services. For you as an investor, this move puts a spotlight on how NYSE:UHS is approaching...

What GATX’s Recent Returns Tell You Right Now GATX (GATX) has given investors a mixed ride recently, with the stock down about 0.8% over the past day and 10.8% over the past month, while the past 3 months are roughly flat. See our latest analysis for GATX. Zooming out, the recent 1 month share price pullback and 7 day share price weakness sit against a share price of US$168.50 and a 1 year total shareholder return of 11.13%. The 5 year total shareholder return of 108.54% points to momentum...

Why Synchrony Financial is on investors’ radar Synchrony Financial (SYF) has drawn attention after a period of weak recent returns, including a 12.5% decline over the past month and a 24.3% decline over the past 3 months. Against that backdrop, investors are revisiting the stock’s fundamentals, including revenue of US$9.76b, net income of US$3.47b, and a value score of 6, to reassess how the current price lines up with the underlying business. See our latest analysis for Synchrony...

Jobs data shock and private credit jitters weigh on Houlihan Lokey (HLI) Houlihan Lokey (HLI) has come under pressure after weak US February jobs data sparked a sell-off in financial stocks, while JPMorgan Chase's tighter lending to private credit providers added further sector stress. See our latest analysis for Houlihan Lokey. Those headline shocks have hit recent momentum hard, with a 7 day share price return of 7.7% and a 30 day decline of 18.1%. The year to date move of 20.9% contrasts...

In early 2026, ComEd, an Exelon subsidiary, rolled out a Low-Income Discount program that has already enrolled about 240,000 customers while the Federal Energy Regulatory Commission approved five transmission security agreements with data center developers to shield existing customers from additional transmission costs. Together with analyst recognition of Exelon’s strong recent earnings and multi‑year capital investment plans, these developments highlight how regulatory support and targeted...

What Nucor’s Recent Share Performance Signals for Investors Nucor (NUE) has recently seen its share price under pressure, with a 1 day return of 1.32%, a 7 day decline of 3.12%, and a month drop of 15.91%. Over the past 3 months, the stock is down 0.99%. Its 1 year total return stands at 25.78%, and its 5 year total return at 147.79%, putting the latest moves in a longer term context. See our latest analysis for Nucor. The recent 30 day share price return of a 15.91% decline suggests momentum...

Why Codexis Is Back on Investors’ Radar Codexis (CDXS) has drawn fresh attention after reporting fourth quarter 2025 results, with revenue of US$38.92 million and net income of US$9.6 million, alongside new full year 2026 revenue guidance. The company also recently signed an agreement to manufacture 50 grams of siRNA for a pharmaceutical partner using its ECO Synthesis platform, adding a commercial data point around its RNA manufacturing capabilities. See our latest analysis for Codexis. At a...